AGIO · Agios Pharmaceuticals, Inc. · Documents
$38.03
+1.18 (+3.20%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$2.27B
Shares
59.70M
Volume · Oct 27
739.1K
Avg daily vol (3M)
1.09M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-11-02 | — | |
| 10-Q | — | 2023-08-03 | 2023-06-30 | |
| 8-K | — | 2023-08-03 | — | |
| 8-K | — | 2023-06-14 | 2023-06-13 | |
| 8-K | — | 2023-05-25 | 2023-05-22 | |
| 8-K | — | 2023-05-04 | — | |
| 10-Q | — | 2023-05-04 | 2023-03-31 | |
| ARS | — | 2023-04-26 | 2022-12-31 | |
| DEFA14A | — | 2023-04-26 | — | |
| DEF 14A | — | 2023-04-26 | — | |
| 8-K | — | 2023-04-19 | 2023-04-17 | |
| 8-K | — | 2023-03-03 | 2023-03-02 | |
| S-3ASR | — | 2023-02-23 | — | |
| 8-K | — | 2023-02-23 | — | |
| 10-K | — | 2023-02-23 | 2022-12-31 | |
| 8-K | — | 2023-01-09 | 2023-01-08 | |
| 8-K | — | 2022-12-16 | 2022-12-12 | |
| 8-K | — | 2022-12-06 | 2022-12-05 | |
| 8-K | — | 2022-11-03 | — | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-10-27 | — | |
| 8-K | — | 2022-10-07 | 2022-10-06 | |
| 8-K | — | 2022-09-19 | 2022-09-15 | |
| 8-K | — | 2022-09-07 | 2022-09-06 | |
| 8-K | — | 2022-08-15 | 2022-08-11 | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-08-04 | — | |
| 8-K | — | 2022-07-12 | 2022-07-07 | |
| 8-K | — | 2022-06-22 | 2022-06-21 | |
| 8-K | — | 2022-05-26 | 2022-05-23 | |
| 8-K | — | 2022-05-18 | 2022-05-15 | |
| 10-Q | — | 2022-05-05 | 2022-03-31 | |
| 8-K | — | 2022-05-05 | — | |
| DEF 14A | — | 2022-04-28 | 2022-06-21 | |
| DEFA14A | — | 2022-04-28 | — | |
| 8-K | — | 2022-04-26 | 2022-04-25 | |
| 8-K | — | 2022-02-24 | — | |
| 10-K | — | 2022-02-24 | 2021-12-31 | |
| 8-K | — | 2022-01-14 | — | |
| 10-Q | — | 2021-11-03 | 2021-09-30 | |
| 8-K | — | 2021-11-03 | — | |
| 8-K | — | 2021-08-04 | 2021-08-01 | |
| 10-Q | — | 2021-07-29 | 2021-06-30 | |
| 8-K | — | 2021-07-29 | 2021-07-27 | |
| 8-K | — | 2021-06-21 | 2021-06-15 | |
| 8-K | — | 2021-06-11 | — | |
| 8-K | — | 2021-05-21 | 2021-05-20 | |
| DEFA14A | — | 2021-05-10 | — | |
| 10-Q/A | — | 2021-05-07 | 2021-03-31 | |
| 8-K | — | 2021-04-29 | — |
Showing 51–100 of 144 filings
Key facts
CIK
1439222
CUSIP
00847X104
13F (30d)
35 filings
35 filers
Visit website
Investor relations